Schroder Investment Management Group Acquires 40,386 Shares of Thermo Fisher Scientific Inc. (TMO)

Schroder Investment Management Group increased its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 3.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,311,886 shares of the medical research company’s stock after acquiring an additional 40,386 shares during the quarter. Schroder Investment Management Group owned about 0.33% of Thermo Fisher Scientific worth $320,205,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. BlackRock Inc. boosted its holdings in Thermo Fisher Scientific by 0.9% in the 3rd quarter. BlackRock Inc. now owns 25,233,243 shares of the medical research company’s stock valued at $6,158,932,000 after purchasing an additional 226,824 shares during the last quarter. FMR LLC boosted its holdings in Thermo Fisher Scientific by 18.5% in the 3rd quarter. FMR LLC now owns 6,499,139 shares of the medical research company’s stock valued at $1,586,310,000 after purchasing an additional 1,016,082 shares during the last quarter. Wells Fargo & Company MN boosted its holdings in Thermo Fisher Scientific by 0.7% in the 3rd quarter. Wells Fargo & Company MN now owns 3,213,226 shares of the medical research company’s stock valued at $784,285,000 after purchasing an additional 23,811 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in Thermo Fisher Scientific by 3.2% in the 2nd quarter. Dimensional Fund Advisors LP now owns 2,670,961 shares of the medical research company’s stock valued at $553,246,000 after purchasing an additional 82,255 shares during the last quarter. Finally, Janus Henderson Group PLC boosted its holdings in Thermo Fisher Scientific by 1.7% in the 2nd quarter. Janus Henderson Group PLC now owns 2,036,659 shares of the medical research company’s stock valued at $421,880,000 after purchasing an additional 34,401 shares during the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Shares of TMO stock traded down $0.91 during trading hours on Friday, hitting $232.11. The company had a trading volume of 11,166 shares, compared to its average volume of 1,719,191. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.27 and a current ratio of 1.84. Thermo Fisher Scientific Inc. has a fifty-two week low of $181.51 and a fifty-two week high of $249.95. The firm has a market cap of $93.81 billion, a P/E ratio of 24.44, a P/E/G ratio of 1.69 and a beta of 1.08.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Wednesday, October 24th. The medical research company reported $2.62 EPS for the quarter, topping the consensus estimate of $2.55 by $0.07. Thermo Fisher Scientific had a net margin of 10.75% and a return on equity of 16.49%. The firm had revenue of $5.92 billion for the quarter, compared to analyst estimates of $5.70 billion. During the same period in the prior year, the business posted $2.31 EPS. The business’s revenue for the quarter was up 15.7% compared to the same quarter last year. As a group, research analysts predict that Thermo Fisher Scientific Inc. will post 11.04 EPS for the current fiscal year.

Thermo Fisher Scientific declared that its Board of Directors has approved a stock repurchase program on Friday, September 7th that authorizes the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization authorizes the medical research company to repurchase up to 2.1% of its stock through open market purchases. Stock repurchase programs are often an indication that the company’s board believes its stock is undervalued.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 15th. Stockholders of record on Monday, December 17th will be issued a $0.17 dividend. The ex-dividend date of this dividend is Friday, December 14th. This represents a $0.68 annualized dividend and a dividend yield of 0.29%. Thermo Fisher Scientific’s dividend payout ratio is currently 7.17%.

In other news, Director Tyler Jacks sold 4,772 shares of the company’s stock in a transaction that occurred on Monday, November 19th. The shares were sold at an average price of $239.75, for a total value of $1,144,087.00. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Marc N. Casper sold 125,520 shares of the company’s stock in a transaction that occurred on Monday, October 1st. The stock was sold at an average price of $247.50, for a total transaction of $31,066,200.00. The disclosure for this sale can be found here. Corporate insiders own 0.49% of the company’s stock.

Several equities analysts have weighed in on the stock. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $259.00 target price on the stock in a report on Monday, July 30th. Leerink Swann boosted their target price on shares of Thermo Fisher Scientific from $239.00 to $255.00 and gave the company an “outperform” rating in a report on Thursday, July 26th. Cleveland Research lowered shares of Thermo Fisher Scientific from a “buy” rating to a “neutral” rating in a report on Thursday, October 18th. Morgan Stanley boosted their target price on shares of Thermo Fisher Scientific from $254.00 to $260.00 and gave the company an “overweight” rating in a report on Thursday, October 25th. Finally, Robert W. Baird boosted their target price on shares of Thermo Fisher Scientific from $256.00 to $264.00 and gave the company an “outperform” rating in a report on Thursday, October 25th. Three research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $263.55.

WARNING: “Schroder Investment Management Group Acquires 40,386 Shares of Thermo Fisher Scientific Inc. (TMO)” was originally published by WKRB News and is the property of of WKRB News. If you are accessing this article on another domain, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this article can be accessed at https://www.wkrb13.com/2018/11/23/schroder-investment-management-group-acquires-40386-shares-of-thermo-fisher-scientific-inc-tmo.html.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Featured Article: Investing in Growth Stocks

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply